Want to see IN:INDSWFTLAB full AI Analyst Report?
Ind-Swift Laboratories Ltd. (INDSWFTLAB) Financial Statements
Ind-Swift Laboratories Ltd. Financial Overview
Ind-Swift Laboratories Ltd.'s market cap is currently $31.95B. The company's EPS TTM is $6.82; its P/E ratio is 53.99; and it has a dividend yield of 1.14%. Ind-Swift Laboratories Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Jun 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.41B | $ 5.62B | $ 12.81B | $ 12.07B | $ 10.39B |
| Gross Profit | $ 1.90B | $ 2.74B | $ 4.13B | $ 4.40B | $ 4.10B |
| Operating Income | $ 144.91M | $ -438.69M | $ 2.01B | $ 1.82B | $ 924.23M |
| EBITDA | $ 450.97M | $ 2.85B | $ 7.82B | $ 2.36B | $ 2.35B |
| Net Income | $ 414.15M | $ 2.50B | $ 4.21B | $ 475.97M | $ -21.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.72B | $ 4.82B | $ 4.94B | $ 231.54M | $ 333.68M |
| Total Assets | $ 16.73B | $ 14.38B | $ 14.60B | $ 18.24B | $ 18.01B |
| Total Debt | $ 205.01M | $ 408.41M | $ 166.22M | $ 8.62B | $ 9.53B |
| Net Debt | $ -4.09B | $ -3.87B | $ -4.15B | $ 8.44B | $ 9.32B |
| Total Liabilities | $ 2.89B | $ 2.65B | $ 6.48B | $ 11.42B | $ 12.00B |
| Stockholders' Equity | $ 13.84B | $ 11.73B | $ 9.36B | $ 6.82B | $ 6.01B |
| Cash Flow | |||||
| Free Cash Flow | $ -1.08B | $ -898.80M | $ -2.08B | $ 1.82B | $ 1.32B |
| Operating Cash Flow | $ -198.64M | $ -254.74M | $ -1.63B | $ 1.95B | $ 1.50B |
| Investing Cash Flow | $ -1.28B | $ -1.10B | $ -1.23B | $ -133.68M | $ 47.72M |
| Financing Cash Flow | $ 1.47B | $ 692.05M | $ 6.99B | $ -1.86B | $ -1.41B |
Currency in INR